Thinking About Its Demise: California Stem Cell Agency Launches Examination of Alternatives
California's $3 billion stem cell research agency, which is facing its financial demise in a few short years, has formed a team of its directors to tackle transition planning and examine possible alternatives, including ones that would extend its life.
The first meeting of the group of directors is tentatively scheduled for Sept. 18. Jonathan Thomas, cha…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.